Last reviewed · How we verify

NCT03457584

Effect of Air-tamponade on Intraretinal Cystoid Changes After Membrane Peeling

Completed NA Last updated 29 September 2020
What this trial tests

NA trial testing air arm in Epiretinal Membrane in 96 participants. Completed in 1 December 2019.

Timeline
1 November 2017
Primary endpoint
1 December 2019
1 December 2019

Quick facts

Lead sponsorVienna Institute for Research in Ocular Surgery
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment96
Start date1 November 2017
Primary completion1 December 2019
Estimated completion1 December 2019
Sites1 location across Austria

Drugs / interventions tested

Conditions studied

Sponsor

Vienna Institute for Research in Ocular Surgery

Who can join

18 and older, any sex, with Epiretinal Membrane. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients with intraretinal cystoid changes before scheduled membrane peeling for epiretinal membranes are included. Patients are randomized for balanced salt solution (BSS) or air-tamponade.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Epiretinal Membrane

Currently open trials in the same condition.

Other Vienna Institute for Research in Ocular Surgery trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03457584.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing